Guardant Health (GH) Tops Q3 EPS by 29c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Guardant Health (GH) PT Raised to $60 at Leerink Partners
November 7, 2024 5:56 AM ESTLeerink Partners analyst Puneet Souda raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: GH addressed two major questions weighing on the shares heading into the quarter: (1) slowdown in its... More
